Drug Design 2 - Applied Bioinformatics Group
Drug Design 2 - Applied Bioinformatics Group
Drug Design 2 - Applied Bioinformatics Group
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
PharmacokineDc ProperDes<br />
• log P, pK a (for acids/bases), and log S play a key role in the<br />
predic%on of the pharmacokine%c proper%es of a compound<br />
• Predic%ng pharmacokine%c proper%es is a non-‐trivial, but<br />
worthwhile, task<br />
• Experimental determina%on of these proper%es is too expensive<br />
for large libraries (e.g., HTS libraries!)<br />
• For many of these proper%es, simple addi%ve models (increment<br />
models) have been developed<br />
• These models assume that the property is given as the sum of the<br />
proper%es of the structural fragments contained in the compound<br />
PredicDon of log P<br />
• We assume that the property of a molecule (e.g., log P) can be<br />
expressed as the contribu%ons of groups<br />
log P = ∑ i a i f i<br />
where a i is the number of fragments of type i occurring in the<br />
structure and f i the fragment‘s contribu%on to log P<br />
• This trivial approach works surprisingly well and can be further<br />
improved through the inclusion of correcDon factors<br />
• These factors compensate for effects like interac%ons between<br />
fragments<br />
Fujita et al., J. Am. Chem. Soc. (1961), 86, 5179<br />
ClogP<br />
• One of the most widely used<br />
approaches for log P predic%on is<br />
ClogP<br />
• ClogP uses a library of fragment<br />
proper%es and correc%on factors<br />
• Fragments are generated by<br />
decomposing the structures at<br />
‘isola%ng carbon atoms’<br />
• These atoms have neither double<br />
nor triple bonds to heteroatoms<br />
F<br />
F<br />
F<br />
OH<br />
NH O<br />
F<br />
F<br />
F<br />
Leo, Chem. Rev. (1993), 93, 1281